Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDIN8bio Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.62 | -$0.62 | -$0.62 |
| Q2 2026 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q3 2026 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q4 2026 | 1 | -$0.35 | -$0.35 | -$0.35 |
| Q1 2027 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q2 2027 | 1 | -$0.41 | -$0.41 | -$0.41 |
| Q3 2027 | 1 | -$0.42 | -$0.42 | -$0.42 |
| Q4 2027 | 1 | -$0.29 | -$0.29 | -$0.29 |
IN8bio Inc Earnings Date And Information
IN8bio Inc last posted its earnings results on Thursday, May 7th, 2026. The company reported $-0.26 earnings per share for the quarter, topping analysts' consensus estimates of $-0.59 by $0.33. The company had revenue of 0 for the quarter and had revenue of 0 for the year. IN8bio Inc has generated $-4 earnings per share over the last year ($-4.44 diluted earnings per share) and currently has a price-to-earnings ratio of -0.37. IN8bio Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
IN8bio Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/07/2026 | Q1 2026 | -$0.59 | -$1.16 | -0.57 | $0 | $0 |
| 03/12/2026 | Q4 2025 | -$0.18 | -$0.51 | -0.33 | $16.00 M | $0 |
| 11/06/2025 | Q3 2025 | -$1.20 | -$0.85 | 0.35 | $5.80 M | $0 |
| 08/07/2025 | Q2 2025 | -$1.50 | -$1.24 | 0.26 | N/A | $0 |
| 05/07/2025 | Q1 2025 | -$1.80 | -$0.07 | 1.73 | N/A | $0 |
| 03/13/2025 | Q4 2024 | -$0.07 | -$0.09 | -0.02 | N/A | $0 |
| 11/12/2024 | Q3 2024 | -$0.14 | -$0.15 | -0.01 | N/A | $0 |
| 08/08/2024 | Q2 2024 | -$0.16 | -$0.19 | -0.03 | N/A | $0 |
| 05/09/2024 | Q1 2024 | -$0.17 | -$0.20 | -0.03 | N/A | $0 |
| 03/14/2024 | Q4 2023 | -$0.16 | -$0.21 | -0.05 | N/A | $0 |
| 11/09/2023 | Q3 2023 | -$0.25 | -$0.23 | 0.02 | N/A | $0 |
| 08/10/2023 | Q2 2023 | -$0.28 | -$0.27 | 0.01 | N/A | $0 |
| 05/12/2023 | Q1 2023 | -$0.33 | -$0.30 | 0.03 | N/A | $0 |
| 03/30/2023 | Q4 2022 | -$0.28 | -$0.32 | -0.04 | N/A | $0 |
| 11/10/2022 | Q3 2022 | -$0.28 | -$0.34 | -0.06 | N/A | $0 |
| 08/12/2022 | Q2 2022 | -$0.33 | -$0.38 | -0.05 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$0.34 | -$0.33 | 0.01 | N/A | $0 |
| 03/17/2022 | Q4 2021 | -$0.21 | -$0.31 | -0.1 | N/A | $0 |
| 11/10/2021 | Q3 2021 | -$0.33 | -$0.18 | 0.15 | N/A | $0 |
| 09/10/2021 | Q2 2021 | -$0.30 | -$0.16 | 0.14 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
IN8bio Inc Earnings: FAQ's
In the previous quarter, IN8bio Inc (:INAB) reported $-0.26 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.59 by $0.33.
The conference call for IN8bio Inc's latest earnings report can be listened to online.
The conference call transcript for IN8bio Inc's latest earnings report can be read online.
IN8bio Inc (:INAB) has a recorded net income of $-19,440,000.IN8bio Inc has generated $-4.44 earnings per share over the last four quarters.
IN8bio Inc (:INAB) has a price-to-earnings ratio of -0.37 and price/earnings-to-growth ratio is 0.